Divi's Laboratories Limited (BOM:532488)
6,285.55
+4.20 (0.07%)
At close: Apr 21, 2026
Divi's Laboratories Revenue
Divi's Laboratories had revenue of 26.04B INR in the quarter ending December 31, 2025, with 12.29% growth. This brings the company's revenue in the last twelve months to 103.14B, up 13.62% year-over-year. In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B with 19.31% growth.
Revenue (ttm)
103.14B
Revenue Growth
+13.62%
P/S Ratio
16.18
Revenue / Employee
9.78M
Employees
10,542
Market Cap
1.67T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 93.60B | 15.15B | 19.31% |
| Mar 31, 2024 | 78.45B | 780.00M | 1.00% |
| Mar 31, 2023 | 77.67B | -11.93B | -13.31% |
| Mar 31, 2022 | 89.60B | 19.90B | 28.56% |
| Mar 31, 2021 | 69.69B | 15.75B | 29.20% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 22.27B |
| Neuland Laboratories | 15.75B |
| Shilpa Medicare | 14.33B |
| Bajaj HealthCare | 6.12B |
| NGL Fine-Chem | 4.47B |
| Anlon Healthcare | 1.70B |
| Sai Parenteral's | 1.63B |
| Gujarat Themis Biosyn | 1.59B |
Divi's Laboratories News
- 5 weeks ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 2 months ago - M&M, Lenskart & more: Stocks to watch out for today - The Times of India
- 2 months ago - Divi's Laboratories Ltd (BOM:532488) Q3 2026 Earnings Call Highlights: Strong Export ... - GuruFocus
- 2 months ago - Q3 2026 Divi's Laboratories Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - What To Expect From Divi's Laboratories Ltd (NSE:DIVISLAB) Q3 2026 Earnings - GuruFocus
- 2 months ago - Pharma sector stocks today, Feb 10: Pfizer rally 9%, GSK Pharma up 4.12%, Divis Laboratories rises 1.47% - Business Upturn
- 4 months ago - Voltas, HCL Tech & more: Stocks to look out for today; check details - The Times of India
- 5 months ago - Nykaa, Bajaj Auto & more: Top stocks on brokers' radar today - The Times of India